期刊文献+

血浆脑钠素在心衰诊断及治疗中的应用探讨 被引量:1

Application of plasma brain natriuretic peptide in diagnosis and treatment of heart failure
下载PDF
导出
摘要 目的探究心衰患者诊断及治疗中血浆脑钠素的应用效果。方法将我院2011年3月~2012年12月接待的79例心衰患者作为研究组,选择同期接待的39例健康人群作为对照组。两组人员皆利用荧光免疫分析技术来对他们的血浆脑钠素水平进行检测,并且利用多普勒超声心电动仪对心衰患者在心室舒张末期的内径(LVEDD)、左心室射血分数(LVEF)及左心室收缩末期内径(LVESD)进行测量,同时采用NYHA(纽约心脏病学会)标准对心功能加以分级。对两组诊断效果进行总结分析及对比。结果研究组在血浆脑钠素浓度上明显高于对照组(P〈0.05),有统计学意义;血浆脑钠素浓度在心功能分级上,I~Ⅱ级、Ⅲ级、Ⅳ级之间差异性显著(P〈0.05),具有统计学意义;此外,血浆脑钠素的水平与LVEDD、LVEF、LVESD的值有着一定的相关性。结论对于心衰患者的诊断而言,血浆脑钠素在其中的意义十分重大,尤其是其可以灵敏的反映心室功能的相关指标,同时这些指标也能很好的指示治疗效果,值得临床推广及应用。 Objective To assess the usefulness of plasma brain natriuretic peptide for the diagnosis and treatment of patients with heart failure. Methods Seventy-nine patients with heart failure who were admitted to our hospital from March 2011 to December 2012 were enrolled as the study group; and 39 healthy subjects who sought consultations at our hospital in the same period were chosen as the control group. Plasma brain natriuretic peptide levels in both groups were determined using fluorescence immunoassay, and left ventricular end-diastolic diameter (LVEDD), left ventrieular ejection fraction (LVEF), and left ventricular end-systolic diameter (LVESD) were measured with Doppler echocardiography. In addition, cardiac function was graded according to the New York Heart Association criteria. Diagnostic results of the two groups were analyzed and compared. Results Plasma brain natriuretic peptide levels were significantly higher in the study group than in the control group (P〈0.05). Plasma brain natriuretic peptide levels showed significant difference across cardiac function grades I, II, III, and IV (P〈0.05). In addition, plasma brain natriuretic peptide levels exhibited some correlation with LVEDD, LVEF, and LVESD. Conclusion Plasma brain natriuretic peptide is of great significance for the diagnosis of heart failure, particularly because it can sensitively reflect relevant indicators of ventricular function. Meanwhile, these indicators can also be used to assess therapeutic efficacy. Therefore, it is necessary to promote their clinical application.
出处 《心血管病防治知识(学术版)》 2013年第8期19-21,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 血浆 脑钠素 心衰 诊断 治疗 Plasma Brain natriuretic peptide Heart failure Diagnosis Treatment
  • 相关文献

参考文献6

二级参考文献38

  • 1刘军锋,贾克刚,刘运德.B型钠尿肽检测在心血管疾病中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):352-354. 被引量:25
  • 2汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 3张孟浪.脑利钠肽与心力衰竭的研究进展[J].现代医药卫生,2006,22(12):1822-1824. 被引量:11
  • 4王静,苑杰,曾强,李春岩.NT-proBNP在心血管疾病诊治中的应用[J].山东医药,2007,47(1):78-79. 被引量:13
  • 5Mair,Friedl W,Thomas S,et al.Natriuretic peptides in assessment of left-ventricular dysfunction[J].Scand Clin Lab Invest Suppl,1999,230:132-142.
  • 6Berdagup P,Caffin P Y,Barazxeri,et al.Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients[J].Am Heart,2006,151:690-698.
  • 7Bayes Genis A,Santalo Bel M,Zapico Muniz E,et al.N-terminal probrain natriurtic peptide (NT-proBNP)in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction[J].Eur Heart Fall,2004,6:301-308.
  • 8Mueller C,Laule Kilsan K,Frana B,et al.Use of B-type natriuretic peptide in the management of acute dyspnoea in patients with pulmonary disease[J].Am Heart L,2006,151:471-477.
  • 9Delemos J A,Morrow D A,Bentley J H,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary sydromes[J].N Engl Med,2001,345:1014-1021.
  • 10Suzuki T,Yamazaki Y.The role of the natriurtic peptides in the cardiovascular system[J].Cardicvasc Res,2001,51:489-494.

共引文献23

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部